The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy

NCT01612182 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1289

Last updated 2012-06-05

No results posted yet for this study

Summary

The prevalence of ESBL Klebsiella pneumonia was higher in patient with renal replacement therapy.

Conditions

  • End-stage Renal Disease

Interventions

OTHER

renal replacement therapy

renal replacement therapy : hemodialysis and/or CRRT(continuous renal replacement therapy )

Sponsors & Collaborators

  • Inje University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Completion
2012-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01612182 on ClinicalTrials.gov